Related Experiment Video

Updated: Jun 12, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes

Barry I Freedman1, Mariana Murea

  • 1Section on Nephrology, Department of Internal Medicine, Wake Forest University, School of Medicine, Winston-Salem, North Carolina 27157-1053, USA. bfreedma@wfubmc.edu

Seminars in Dialysis
|May 25, 2010
PubMed

Insights

Genetic variants in the nonmuscle myosin heavy chain 9 (MYH9) gene are linked to kidney disease disparities. Understanding MYH9

Area of Science:

  • Nephrology and Genetics

Background:

  • Nonmuscle myosin heavy chain 9-associated nephropathy encompasses several related kidney disorders.
  • The nonmuscle myosin heavy chain 9 (MYH9) gene plays a significant role in inherited kidney diseases.
  • MYH9 gene variants contribute to ethnic variations in end-stage renal disease incidence.

Purpose of the Study:

  • To highlight the established role of MYH9 gene variants in kidney disease.
  • To explore the potential impact of MYH9 on clinical outcomes in patients with kidney disease, including those on dialysis and post-transplantation.
  • To emphasize the clinical relevance of recognizing MYH9 gene effects in severe kidney disease management.

Main Methods:

  • This abstract is based on a review of existing literature and established genetic associations.
  • No new experimental data were generated; the focus is on summarizing current understanding.

Main Results:

  • The contribution of MYH9 gene variants to ethnic differences in end-stage renal disease rates is well-established.
  • MYH9 gene variants are associated with inherited kidney disorders.
  • Polymorphisms in MYH9 may influence treatment outcomes in severe kidney disease.

Conclusions:

  • Recognizing the role of MYH9 in inherited nephropathies is crucial for understanding disease associations.
  • MYH9 gene variants may impact patient outcomes, including those undergoing dialysis or kidney transplantation.
  • The influence of MYH9 gene effects on treatment outcomes in severe kidney disease warrants further attention in clinical practice.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...